Clinical operations note: cheapest-isn039t-cheaper-why-i-calculate-tco-on-every-medical-supply-order-132

The Price Is Not the Cost

The cheapest quote is rarely the least expensive purchase. I know that sounds like a contradiction, but after five years of managing medical supply orders, I've learned to assume it's true.

I'm the purchasing administrator for a 230-bed regional hospital. I manage about $4.5 million in annual medical-surgical supply spend across 35 vendors. I report to the operations director and the CFO. I'm not a clinician, so I can't tell you which device is clinically better. What I can tell you from the procurement side is this: unit price is a small piece of total cost.

Why I Started Calculating TCO

In 2021, when I took over purchasing, I made the mistake a lot of new buyers make. I found a supplier with prices 15% below our incumbent. The samples looked fine. The invoice was clean. The first order arrived on time. By the third order, the products were inconsistent. One batch of IV catheter tips didn't seat the same way. Nurses started complaining. Some ended up wasted because they couldn't be set up reliably. I had to pull the supply from three floors and restock. The savings disappeared inside labor, waste, and the loss of trust from the nursing staff.

That was my unit price is a lie moment. Since then, I calculate total cost of ownership on every product category that goes through our procurement department.

It Applies to the Small Stuff

Take the humble peripheral IV catheter. One vendor might offer a box at $38. Another is $62. At first glance, you'd be an idiot to pay $62. But the real cost includes how often the catheter fails, how many need to be replaced due to dislodgement or occlusion, how much nursing time is tied up in restarts, and how the device fits our charting workflow.

I'm not a nurse, so I won't lecture anyone on insertion technique. What I see in our data: if the cheaper catheter causes even one extra restart per 10 insertions, the labor cost can wipe out the $24 price gap. If it causes more waste, the gap disappears entirely. The cheap catheter isn't cheap. It's just priced cheap. Cheap is a price. Cost is a ledger.

The Surgical Stapler Question

Another product that shows up in supply requisitions is the surgical stapler. If you've ever wondered what is a surgical stapler?—it's a device that places rows of surgical staples to close tissue, seal vessels, and make anastomoses in surgery. The stapler is usually single-use, and surgeons can be picky. They have a reason: if a stapler jams or doesn't fire cleanly, the surgeon has to shift attention from the patient to the instrument.

OR time at a hospital like ours can run between $30 and $60 per minute, depending on the service line. A single malfunction that adds 15 minutes to a case can cost more than the price difference between a low-end and high-end stapler. And that's before you count the cost of removing a faulty device, opening a new one, or explaining the delay to the patient's family.

I can't tell you that the expensive stapler is clinically better. But the hospital budget sees the failure either way. When I review utilization reports with the OR director, we don't talk about list prices. We talk about misfires, reloads, and total time on cases. Those are TCO metrics.

The Vendor Behind the Product Matters

Then there's the layer that many procurement teams overlook: the vendor itself. A cheap line of implants or monitoring devices isn't a bargain if the company changes direction, discontinues the line, or can't support training and service.

This is why I follow company news. Globus Medical is a good example. The company, founded in 2003, is younger than many orthopedic incumbents. That could be a disadvantage. Instead, it has expanded through strategic acquisitions. The Globus Medical acquisition of Nevro in 2025 is a notable move because it adds neuromodulation and pain management to an already broad portfolio. From a purchasing perspective, that tells me the company is investing for the long term. It also suggests their product lines will keep evolving, which matters when you're writing contracts that can last two to five years.

I'm not recommending one vendor over another. I'm recommending that you evaluate vendor stability as part of cost. A product from a stable manufacturer with training, reimbursement support, and a clear roadmap will usually have a lower TCO than an orphan device at a great price.

FDA clearance is another piece of it. A device can get cleared and still have no clear reimbursement code. That can delay a hospital's revenue cycle for weeks. A vendor that helps you navigate regulation and payer requirements is providing something the purchase order doesn't show. If they don't, you carry that cost.

Remote Patient Monitoring Is TCO in Disguise

One area growing fast is remote patient monitoring. The hardware can look cheap on a purchase order. The hidden costs are integration, workflow, and support.

Does the device sync with your electronic health record automatically? If not, someone has to type the vitals into the chart. That's not just labor—it's also the risk of transcription errors. Does the platform show trends, or does it just dump data? Can the vendor support two-way data exchange with your existing systems? If you have to build a custom interface, your IT team becomes part of every order, and their time is not billed on the original quote.

In our 2024 vendor consolidation project, we discovered that two cheap remote monitoring brands would have required manual data entry for every patient. The extra nursing time alone came to about $18,000 a year for the volume we projected. That changed our decision—not because the hardware was bad, but because the TCO made the higher-priced option cheaper in the long run.

But What About Budgets?

I get the pushback. Budgets are real. The CFO's approval sheet has a unit price column, and you can't write the letters TCO in the margin and expect finance to sign. I've been there. Even after I made the case for a more expensive IV catheter line, I spent a month second-guessing. What if the higher price didn't translate into savings? The data eventually showed fewer restarts and less waste, but the wait was stressful.

The most frustrating part of this job is the line-item budget. You can explain TCO in a meeting, and the spreadsheet still asks why a line is 14% higher than last year. So here's what works for me: present TCO not as a philosophy but as a calculation. Show the projected cost of restarts, OR delays, and manual data entry. Once the finance team sees the numbers in the same units as their budget, the conversation changes.

This isn't about always buying premium. If two products have similar TCO, I take the lower unit price and celebrate. But I won't let a low unit price be the headline until I've checked the total cost.

Bottom Line

The market has plenty of cheap medical supplies. It has fewer cheap purchases. Globus Medical was founded in 2003 and grew into a major spine and orthopedics player by building a broad portfolio—sometimes through acquisitions like the one with Nevro in 2025. That growth didn't happen by selling devices that cost hospitals more in the long run. It happened by offering products that solve the whole problem, not just the line item.

So next time you compare an IV catheter quote or look up what is a surgical stapler as you evaluate OR supplies, ask a better question: What will this product cost us six months from now? That's the number I want on my ledger.